1. Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data 
Kathleen Lang, Lisa J. McGarry, Huan Huang, David Dorer, Elise Kaufman, Kevin Knopf 
Clinical Lymphoma, Myeloma and Leukemia 
Volume 16, Issue 5, Pages e1 (May 2016)
DOI: /j.clml
Copyright © 2016 The Authors Terms and Conditions

2. Figure 1 Patient Selection
Abbreviations: CML = chronic myeloid leukemia; SEER = Surveillance, Epidemiology, and End Results.
Clinical Lymphoma, Myeloma and Leukemia  , e1DOI: ( /j.clml )
Copyright © 2016 The Authors Terms and Conditions

3. Figure 2
Kaplan-Meier Survival Curve for Patients With Chronic Myeloid Leukemia (CML) and Matched Noncancer Patients
Abbreviation: TKI = tyrosine kinase inhibitor.
Clinical Lymphoma, Myeloma and Leukemia  , e1DOI: ( /j.clml )
Copyright © 2016 The Authors Terms and Conditions

4. Figure 3
Rates of Myocardial Infarction (MI), Stroke, Pulmonary Embolism (PE), and Peripheral Arterial Disease (PAD) for Patients With Chronic Myeloid Leukemia (CML) and Matched Noncancer Patients
Abbreviation: TKI = tyrosine kinase inhibitor.
Clinical Lymphoma, Myeloma and Leukemia  , e1DOI: ( /j.clml )
Copyright © 2016 The Authors Terms and Conditions